Clinical trials in Australia are initiated based on approval of a Human Research Ethics Committee, not Australia’s Therapeutic Goods Administration (TGA), and TGA also lacks a routine inspection program to check whether clinical trials are complying with good clinical practice (GCP). TGA is now planning a GCP inspection pilot program as a stepping stone to a permanent, routine GCP inspection program. (Regulatory Focus)